Oral News and Research

RSS

Cipher to distribute Can-Fite’s CF101 for plaque psoriasis and rheumatoid arthritis treatment in Canada

Cipher Pharmaceuticals Inc. today announced it has licensed the Canadian distribution rights to CF101, a novel chemical entity being developed by Can-Fite Biopharma for moderate to severe plaque psoriasis and rheumatoid arthritis.

23 Mar 2015

Acne patients not getting medications prescribed by their dermatologists

Medicine obviously can't do much good if it sits on a pharmacy shelf. Yet more than one-quarter of the acne patients surveyed by Wake Forest Baptist Medical Center researchers didn't get medications prescribed by their dermatologists.

23 Mar 2015

Study explains why generic insulin remains out of reach for diabetes patients

A generic version of insulin, the lifesaving diabetes drug used by 6 million people in the United States, has never been available in this country because drug companies have made incremental improvements that kept insulin under patent from 1923 to 2014.

23 Mar 2015

MED15 may serve as prognostic marker for HNSCC recurrence

A new study provides the first evidence that the mediator complex subunit 15 (MED15) may play a crucial role in the pathophysiology of head and neck squamous cell carcinoma (HNSCC). MED15 overexpression was found to be associated with higher mortality rates in HNSCC patients with cancer recurrence, particularly in oral cavity/oropharyngeal tumors, according to the study published in The American Journal of Pathology.

21 Mar 2015

Mutations in hair keratins increase risk for dental defects, caries

Today at the 93rd General Session and Exhibition of the International Association for Dental Research, researcher Olivier Duverger, National Institutes of Health-National Institute of Neurological Disorders and Stroke, Bethesda, Md., USA, will present a study titled "Hair Keratins as Structural Organic Components of Mature Enamel: The Link Between Hair Disorders and Susceptibility to Dental Caries."

20 Mar 2015

Case Western Reserve professor urges action to eliminate yaws

Half a century ago, a concentrated global effort nearly wiped a disfiguring tropical disease from the face of the earth. Now, says Case Western Reserve's James W. Kazura, MD, it's time to complete the work.

20 Mar 2015

New pre-clinical, clinical data for IMBRUVICA to be highlighted at AACR Annual Meeting

Pharmacyclics, Inc. today announced that new pre-clinical and clinical data for ibrutinib (IMBRUVICA) will be highlighted at the 2015 American Association for Cancer Research Annual Meeting to be held April 18 – 22, 2015, in Philadelphia, PA.

19 Mar 2015

New research project aims to improve oral health among children

A new research project from the University of Copenhagen has established an effective model for the fight against the escalating burden of tooth decay among children in Asia. The model is an important tool in breaking the social inequity in oral health of children.

19 Mar 2015

Daiichi Sankyo signs co-commercialization agreement with AstraZeneca for MOVANTIK (naloxegol)

Daiichi Sankyo, Inc. today announced a co-commercialization agreement with AstraZeneca for MOVANTIK (naloxegol) in the US, in line with the Daiichi Sankyo strategy to expand its US portfolio through strategic alliances, in addition to internal R&D and acquisitions.

19 Mar 2015

New research identifies promising drug therapy target for breast cancer

The genome of a cell is under constant attack, suffering DNA damage that requires an army of repair mechanisms to keep the cell healthy and alive. Understanding the behavior of the enzymes defending these assaults helps determine how - and where - cancer gets its foothold and flourishes.

18 Mar 2015

Pharmalink AB acquires anti-inflammatory drug candidate from Synartro AB

Pharmalink AB, a specialty pharma company, announces that it has acquired a novel product candidate in development for treating inflammation from Synartro AB. No financial details are disclosed.

18 Mar 2015

Sildenafil drug may effectively relieve nerve damage in men with long-term diabetes

New animal studies at Henry Ford Hospital found that sildenafil, a drug commonly used to treat erectile dysfunction, may be effective in relieving painful and potentially life-threatening nerve damage in men with long-term diabetes.

18 Mar 2015

Broad array of clinical, health care policy topics to be featured at ACP's Internal Medicine Meeting

More than 6,000 internal medicine physicians, subspecialists, medical students, and allied health professionals from around the world will gather for the American College of Physicians' Internal Medicine Meeting 2015 from April 30 through May 2 (Thursday - Saturday) at the Boston Convention and Exhibition Center.

17 Mar 2015

UNICEF dispatches emergency supplies to children in cyclone-affected Vanuatu

While distributing its pre-positioned emergency supplies in Vanuatu, UNICEF also has dispatched additional life-saving supplies for affected communities from its Pacific regional warehouse in Suva, Fiji. This includes health, education, child protection, and water, sanitation and hygiene (WASH) supplies.

17 Mar 2015

New hepatitis C drugs to place economic burden on health care system, predicts MD Anderson study

The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country's health care system. The prediction comes from a cost-effectiveness analysis led by researchers at The University of Texas MD Anderson Cancer Center.

17 Mar 2015

Results of pacritinib Phase 2 study in myelofibrosis patients published in journal 'Blood'

CTI BioPharma Corp. today announced that results of a Phase 2 study of pacritinib, in patients with myelofibrosis were published in the journal Blood. Pacritinib is a next-generation oral JAK2/FLT3 multikinase inhibitor currently in Phase 3 development in the PERSIST program.

16 Mar 2015

Nomogram aids management of boys with constitutional delay in growth and puberty

A puberty nomogram is better than the classical criteria for identifying boys with constitutional delay in growth and puberty, report researchers.

13 Mar 2015

Researchers investigate effects of neuromodulatory medication on orofacial tissue

Today at the 93rd General Session and Exhibition of the International Association for Dental Research, researcher M.J. Al-Musawi, Newcastle University, Newcastle upon Tyne, UK, will present a study titled "In Vitro Effects of Topical Neuromodulatory Medication on Orofacial Tissue."

13 Mar 2015

Guanabenz drug prevents myelin loss, alleviates symptoms of MS in animal models

An FDA-approved drug for high blood pressure, guanabenz, prevents myelin loss and alleviates clinical symptoms of multiple sclerosis (MS) in animal models, according to a new study.

13 Mar 2015

Spherix provides update on September 2014 request for inter parties review by VTech, and Uniden

Spherix Incorporated -- an intellectual property development company committed to the fostering and monetization of intellectual property, today provided an update on the September 2014 request for inter parties review by VTech Communications, Inc. and Uniden America Corporation.

13 Mar 2015

Oral News and Research

Cipher to distribute Can-Fite’s CF101 for plaque psoriasis and rheumatoid arthritis treatment in Canada

Acne patients not getting medications prescribed by their dermatologists

Study explains why generic insulin remains out of reach for diabetes patients

MED15 may serve as prognostic marker for HNSCC recurrence

Mutations in hair keratins increase risk for dental defects, caries

Case Western Reserve professor urges action to eliminate yaws

New pre-clinical, clinical data for IMBRUVICA to be highlighted at AACR Annual Meeting

New research project aims to improve oral health among children

Daiichi Sankyo signs co-commercialization agreement with AstraZeneca for MOVANTIK (naloxegol)

New research identifies promising drug therapy target for breast cancer

Pharmalink AB acquires anti-inflammatory drug candidate from Synartro AB

Sildenafil drug may effectively relieve nerve damage in men with long-term diabetes

Broad array of clinical, health care policy topics to be featured at ACP's Internal Medicine Meeting

UNICEF dispatches emergency supplies to children in cyclone-affected Vanuatu

New hepatitis C drugs to place economic burden on health care system, predicts MD Anderson study

Results of pacritinib Phase 2 study in myelofibrosis patients published in journal 'Blood'

Nomogram aids management of boys with constitutional delay in growth and puberty

Researchers investigate effects of neuromodulatory medication on orofacial tissue

Guanabenz drug prevents myelin loss, alleviates symptoms of MS in animal models

Spherix provides update on September 2014 request for inter parties review by VTech, and Uniden

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News